0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025
Published Date: May 2019
|
Report Code: QYRE-Auto-3Z503
Home | Market Reports | Health | Health Conditions | Neurological Conditions
Global Multiple Sclerosis Market Size Status and Forecast 2019 2025

Global Multiple Sclerosis Market Size, Status and Forecast 2019-2025

Code: QYRE-Auto-3Z503
Report
May 2019
Pages:93
QYResearch
Description
Table of Content
Tables & Figures
Multiple sclerosis is a chronic, inflammatory medical condition, which results in demyelination, axonal transection, and neurodegeneration of the nerve cells of the brain and spinal cord. The immune system of the body targets the neurons within the CNS and damages the myelin sheath. It is a potentially debilitating disease, causing disruption in the communication and coordination functions of the body. The symptoms of multiple sclerosis differ widely, subject to the extent of damage and the number of neurons affected. Some of the symptoms observed are fatigue, numbness, spasticity, bladder dysfunction, cognitive changes, emotional changes, and depression. An individual with severe form of the disease can experience speech and movement problems.
Nevertheless, the leading pharmaceutical companies operating in North America and Europe is shifting the focus on Asia-pacific region due to the growing demand for effective and economic MS treatment. . Pharmaceutical companies belong to developed regions are focusing on the commercialization of novel therapeutics having minimal side effects and economic pricing. Such product launch strategy would provide an opportunity for the pharmaceutical companies across developing economies. Furthermore, the market is majorly supplemented by increasing funding from government authorities for research and development.
In 2018, the global Multiple Sclerosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Multiple Sclerosis development in United States, Europe and China.

The key players covered in this study
    Abbvie
    Acorda Therapeutics
    Bayer HealthCare
    Biogen
    Genzyme (Sanofi)
    GlaxoSmithKline
    Merck Serono
    Novartis
    Pfizer
    Teva

Market segment by Type, the product can be split into
    Injectable agents
    Oral agents

Market segment by Application, split into
    Hosptial
    Research

Market segment by Regions/Countries, this report covers
    United States
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

The study objectives of this report are:
    To analyze global Multiple Sclerosis status, future forecast, growth opportunity, key market and key players.
    To present the Multiple Sclerosis development in United States, Europe and China.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Multiple Sclerosis are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Key Market Segments
    1.3 Players Covered
    1.4 Market Analysis by Type
        1.4.1 Global Multiple Sclerosis Market Size Growth Rate by Type (2014-2025)
        1.4.2 Injectable agents
        1.4.3 Oral agents
    1.5 Market by Application
        1.5.1 Global Multiple Sclerosis Market Share by Application (2014-2025)
        1.5.2 Hosptial
        1.5.3 Research
    1.6 Study Objectives
    1.7 Years Considered

2 Global Growth Trends
    2.1 Multiple Sclerosis Market Size
    2.2 Multiple Sclerosis Growth Trends by Regions
        2.2.1 Multiple Sclerosis Market Size by Regions (2014-2025)
        2.2.2 Multiple Sclerosis Market Share by Regions (2014-2019)
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers
        2.3.3 Market Opportunities

3 Market Share by Key Players
    3.1 Multiple Sclerosis Market Size by Manufacturers
        3.1.1 Global Multiple Sclerosis Revenue by Manufacturers (2014-2019)
        3.1.2 Global Multiple Sclerosis Revenue Market Share by Manufacturers (2014-2019)
        3.1.3 Global Multiple Sclerosis Market Concentration Ratio (CR5 and HHI)
    3.2 Multiple Sclerosis Key Players Head office and Area Served
    3.3 Key Players Multiple Sclerosis Product/Solution/Service
    3.4 Date of Enter into Multiple Sclerosis Market
    3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
    4.1 Global Multiple Sclerosis Market Size by Type (2014-2019)
    4.2 Global Multiple Sclerosis Market Size by Application (2014-2019)

5 United States
    5.1 United States Multiple Sclerosis Market Size (2014-2019)
    5.2 Multiple Sclerosis Key Players in United States
    5.3 United States Multiple Sclerosis Market Size by Type
    5.4 United States Multiple Sclerosis Market Size by Application

6 Europe
    6.1 Europe Multiple Sclerosis Market Size (2014-2019)
    6.2 Multiple Sclerosis Key Players in Europe
    6.3 Europe Multiple Sclerosis Market Size by Type
    6.4 Europe Multiple Sclerosis Market Size by Application

7 China
    7.1 China Multiple Sclerosis Market Size (2014-2019)
    7.2 Multiple Sclerosis Key Players in China
    7.3 China Multiple Sclerosis Market Size by Type
    7.4 China Multiple Sclerosis Market Size by Application

8 Japan
    8.1 Japan Multiple Sclerosis Market Size (2014-2019)
    8.2 Multiple Sclerosis Key Players in Japan
    8.3 Japan Multiple Sclerosis Market Size by Type
    8.4 Japan Multiple Sclerosis Market Size by Application

9 Southeast Asia
    9.1 Southeast Asia Multiple Sclerosis Market Size (2014-2019)
    9.2 Multiple Sclerosis Key Players in Southeast Asia
    9.3 Southeast Asia Multiple Sclerosis Market Size by Type
    9.4 Southeast Asia Multiple Sclerosis Market Size by Application

10 India
    10.1 India Multiple Sclerosis Market Size (2014-2019)
    10.2 Multiple Sclerosis Key Players in India
    10.3 India Multiple Sclerosis Market Size by Type
    10.4 India Multiple Sclerosis Market Size by Application

11 Central & South America
    11.1 Central & South America Multiple Sclerosis Market Size (2014-2019)
    11.2 Multiple Sclerosis Key Players in Central & South America
    11.3 Central & South America Multiple Sclerosis Market Size by Type
    11.4 Central & South America Multiple Sclerosis Market Size by Application

12 International Players Profiles
    12.1 Abbvie
        12.1.1 Abbvie Company Details
        12.1.2 Company Description and Business Overview
        12.1.3 Multiple Sclerosis Introduction
        12.1.4 Abbvie Revenue in Multiple Sclerosis Business (2014-2019)
        12.1.5 Abbvie Recent Development
    12.2 Acorda Therapeutics
        12.2.1 Acorda Therapeutics Company Details
        12.2.2 Company Description and Business Overview
        12.2.3 Multiple Sclerosis Introduction
        12.2.4 Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)
        12.2.5 Acorda Therapeutics Recent Development
    12.3 Bayer HealthCare
        12.3.1 Bayer HealthCare Company Details
        12.3.2 Company Description and Business Overview
        12.3.3 Multiple Sclerosis Introduction
        12.3.4 Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)
        12.3.5 Bayer HealthCare Recent Development
    12.4 Biogen
        12.4.1 Biogen Company Details
        12.4.2 Company Description and Business Overview
        12.4.3 Multiple Sclerosis Introduction
        12.4.4 Biogen Revenue in Multiple Sclerosis Business (2014-2019)
        12.4.5 Biogen Recent Development
    12.5 Genzyme (Sanofi)
        12.5.1 Genzyme (Sanofi) Company Details
        12.5.2 Company Description and Business Overview
        12.5.3 Multiple Sclerosis Introduction
        12.5.4 Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)
        12.5.5 Genzyme (Sanofi) Recent Development
    12.6 GlaxoSmithKline
        12.6.1 GlaxoSmithKline Company Details
        12.6.2 Company Description and Business Overview
        12.6.3 Multiple Sclerosis Introduction
        12.6.4 GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)
        12.6.5 GlaxoSmithKline Recent Development
    12.7 Merck Serono
        12.7.1 Merck Serono Company Details
        12.7.2 Company Description and Business Overview
        12.7.3 Multiple Sclerosis Introduction
        12.7.4 Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)
        12.7.5 Merck Serono Recent Development
    12.8 Novartis
        12.8.1 Novartis Company Details
        12.8.2 Company Description and Business Overview
        12.8.3 Multiple Sclerosis Introduction
        12.8.4 Novartis Revenue in Multiple Sclerosis Business (2014-2019)
        12.8.5 Novartis Recent Development
    12.9 Pfizer
        12.9.1 Pfizer Company Details
        12.9.2 Company Description and Business Overview
        12.9.3 Multiple Sclerosis Introduction
        12.9.4 Pfizer Revenue in Multiple Sclerosis Business (2014-2019)
        12.9.5 Pfizer Recent Development
    12.10 Teva
        12.10.1 Teva Company Details
        12.10.2 Company Description and Business Overview
        12.10.3 Multiple Sclerosis Introduction
        12.10.4 Teva Revenue in Multiple Sclerosis Business (2014-2019)
        12.10.5 Teva Recent Development

13 Market Forecast 2019-2025
    13.1 Market Size Forecast by Regions
    13.2 United States
    13.3 Europe
    13.4 China
    13.5 Japan
    13.6 Southeast Asia
    13.7 India
    13.8 Central & South America
    13.9 Market Size Forecast by Product (2019-2025)
    13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            12.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Disclaimer
    15.3 Author Details
List of Tables and Figures

    Table Multiple Sclerosis Key Market Segments
    Table Key Players Multiple Sclerosis Covered
    Table Global Multiple Sclerosis Market Size Growth Rate by Type 2014-2025 (Million US$)
    Figure Global Multiple Sclerosis Market Size Market Share by Type 2014-2025
    Figure Injectable agents Figures
    Table Key Players of Injectable agents
    Figure Oral agents Figures
    Table Key Players of Oral agents
    Table Global Multiple Sclerosis Market Size Growth by Application 2014-2025 (Million US$)
    Figure Hosptial Case Studies
    Figure Research Case Studies
    Figure Multiple Sclerosis Report Years Considered
    Table Global Multiple Sclerosis Market Size 2014-2025 (Million US$)
    Figure Global Multiple Sclerosis Market Size and Growth Rate 2014-2025 (Million US$)
    Table Global Multiple Sclerosis Market Size by Regions 2014-2025 (Million US$)
    Table Global Multiple Sclerosis Market Size by Regions 2014-2019 (Million US$)
    Table Global Multiple Sclerosis Market Share by Regions 2014-2019
    Figure Global Multiple Sclerosis Market Share by Regions 2014-2019
    Figure Global Multiple Sclerosis Market Share by Regions 2019
    Table Market Top Trends
    Table Global Multiple Sclerosis Revenue by Manufacturers (2014-2019) (Million US$)
    Table Global Multiple Sclerosis Market Share by Manufacturers (2014-2019)
    Figure Global Multiple Sclerosis Market Share by Manufacturers in 2018
    Table Global Multiple Sclerosis Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Players Head office and Area Served
    Table Key Players Multiple Sclerosis Product/Solution/Service
    Table Date of Enter into Multiple Sclerosis Market
    Table Mergers & Acquisitions, Expansion Plans
    Table Global Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table Global Multiple Sclerosis Market Size Share by Type (2014-2019)
    Figure Global Multiple Sclerosis Market Size Market Share by Type (2014-2019)
    Table Global Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table Global Multiple Sclerosis Market Size Share by Application (2014-2019)
    Figure Global Multiple Sclerosis Market Size Market Share by Application (2014-2019)
    Figure Global Multiple Sclerosis Revenue Market Share by Application in 2018
    Figure United States Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table United States Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table United States Key Players Multiple Sclerosis Market Share (2018-2019)
    Table United States Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table United States Multiple Sclerosis Market Share by Type (2014-2019)
    Table United States Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table United States Multiple Sclerosis Market Share by Application (2014-2019)
    Figure Europe Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table Europe Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table Europe Key Players Multiple Sclerosis Market Share (2018-2019)
    Table Europe Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table Europe Multiple Sclerosis Market Share by Type (2014-2019)
    Table Europe Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table Europe Multiple Sclerosis Market Share by Application (2014-2019)
    Figure China Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table China Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table China Key Players Multiple Sclerosis Market Share (2018-2019)
    Table China Multiple Sclerosis Market Size by Type (2014-20189) (Million US$)
    Table China Multiple Sclerosis Market Share by Type (2014-2019)
    Table China Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table China Multiple Sclerosis Market Share by Application (2014-2019)
    Figure Japan Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table Japan Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table Japan Key Players Multiple Sclerosis Market Share (2018-2019)
    Table Japan Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table Japan Multiple Sclerosis Market Share by Type (2014-2019)
    Table Japan Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table Japan Multiple Sclerosis Market Share by Application (2014-2019)
    Figure Southeast Asia Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table Southeast Asia Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table Southeast Asia Key Players Multiple Sclerosis Market Share (2018-2019)
    Table Southeast Asia Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table Southeast Asia Multiple Sclerosis Market Share by Type (2014-2019)
    Table Southeast Asia Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table Southeast Asia Multiple Sclerosis Market Share by Application (2014-2019)
    Figure India Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table India Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table India Key Players Multiple Sclerosis Market Share (2018-2019)
    Table India Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table India Multiple Sclerosis Market Share by Type (2014-2019)
    Table India Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table India Multiple Sclerosis Market Share by Application (2014-2019)
    Figure Central & South America Multiple Sclerosis Market Size 2014-2019 (Million US$)
    Table Central & South America Key Players Multiple Sclerosis Revenue (2018-2019) (Million US$)
    Table Central & South America Key Players Multiple Sclerosis Market Share (2018-2019)
    Table Central & South America Multiple Sclerosis Market Size by Type (2014-2019) (Million US$)
    Table Central & South America Multiple Sclerosis Market Share by Type (2014-2019)
    Table Central & South America Multiple Sclerosis Market Size by Application (2014-2019) (Million US$)
    Table Central & South America Multiple Sclerosis Market Share by Application (2014-2019)
    Table Abbvie Company Details
    Table Abbvie Revenue in Multiple Sclerosis Business (2014-2019) (Million US$)
    Figure Abbvie Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Abbvie Recent Development
    Table Acorda Therapeutics Company Details
    Table Acorda Therapeutics Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Acorda Therapeutics Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Acorda Therapeutics Recent Development
    Table Bayer HealthCare Company Details
    Table Bayer HealthCare Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Bayer HealthCare Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Bayer HealthCare Recent Development
    Table Biogen Company Details
    Table Biogen Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Biogen Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Biogen Recent Development
    Table Genzyme (Sanofi) Company Details
    Table Genzyme (Sanofi) Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Genzyme (Sanofi) Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Genzyme (Sanofi) Recent Development
    Table GlaxoSmithKline Company Details
    Table GlaxoSmithKline Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure GlaxoSmithKline Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table GlaxoSmithKline Recent Development
    Table Merck Serono Company Details
    Table Merck Serono Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Merck Serono Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Merck Serono Recent Development
    Table Novartis Company Details
    Table Novartis Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Novartis Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Novartis Recent Development
    Table Pfizer Company Details
    Table Pfizer Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Pfizer Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Pfizer Recent Development
    Table Teva Company Details
    Table Teva Revenue in Multiple Sclerosis Business (2014-2019)(Million US$)
    Figure Teva Revenue Growth Rate in Multiple Sclerosis Business (2014-2019)
    Table Teva Recent Development
    Table Global Multiple Sclerosis Market Size by Regions (Million US$) 2019-2025
    Figure Global Multiple Sclerosis Market Size Share by Regions (2019-2025)
    Figure Global Multiple Sclerosis Market Size Share by Regions in 2025
    Figure United States Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Figure Europe Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Figure China Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Figure Japan Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Figure Southeast Asia Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Figure India Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Figure Central & South America Multiple Sclerosis Market Size Forecast (2019-2025)(Million USD)
    Table Global Multiple Sclerosis Market Size by Product (2019-2025) (Million US$)
    Figure Global Multiple Sclerosis Market Size by Product (2019-2025)
    Figure Global Multiple Sclerosis Market Size by Product in 2025
    Table Global Multiple Sclerosis Market Size by Application (2019-2025) (Million US$)
    Figure Global Multiple Sclerosis Market Size by Application (2019-2025)
    Figure Global Multiple Sclerosis Market Size by Application in 2025
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3900

This license allows only one user(purchaser of the report) to access the PDF.
Electronic (PDF)

$5850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Nano Dimension
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Progressive Supranuclear Palsy Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-37D8375
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Autism Spectrum Disorder Diagnosis and Therapeutics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38J12701
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Essential Tremor Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-041
Fri Feb 23 00:00:00 UTC 2024

Add to Cart

Global Developmental and Epileptic Encephalopathies (DEE) Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-22N8285
Thu Feb 22 00:00:00 UTC 2024

Add to Cart